flxn-ex231_1040.htm

EX-23.1 5 flxn-ex231_1040.htm EX-23.1 flxn-ex231_1040.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-193907, 333-202957 and 333-210111) of Flexion Therapeutics, Inc. of our report dated March 10, 2017 relating to the financial statements, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts
March 10, 2017